Merck’s newly approved vaccine, Capvaxive, comes as a breakthrough in protecting adults from the serious bacteria known as pneumococcus. This bacteria can lead to severe illnesses and even pneumonia, particularly affecting older patients and those with chronic health conditions. The introduction of Capvaxive aims to provide broader protection than the currently available vaccines on the
0 Comments
The Municipal Securities Rulemaking Board has taken a significant step towards enhancing market transparency by adding the Tradeweb AAA Municipal Curve to its Electronic Municipal Market Access website. This move is part of a broader effort to consolidate more data on EMMA, providing investors with valuable tools to evaluate bond prices and yields, measure market
0 Comments
Federal Reserve Bank of Philadelphia President Patrick Harker emphasized the importance of remaining data-dependent in determining the timing and number of rate cuts this year. According to Harker, basing decisions on incoming data is crucial in navigating uncertainty and ensuring that inflation returns to target levels in a sustainable manner. This approach reflects a cautious
0 Comments
Goldman Sachs recently upgraded Toll Brothers, a construction stock, citing the company’s potential to benefit from the ongoing building demand. Analyst Susan Maklari expressed confidence in Toll Brothers’ revenues, profitability, and returns, leading to a more optimistic outlook. The price target was raised to $124 per share, indicating a 4% upside from the previous close
0 Comments